|
GLRX5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95199412189595E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.01734201460613E-12 |
| Normal-vs-Stage2 |
9.88520043598839E-10 |
| Normal-vs-Stage3 |
1.34270372598166E-11 |
| Normal-vs-Stage4 |
1.88740001405563E-09 |
| Stage1-vs-Stage2 |
2.410200E-01 |
| Stage1-vs-Stage3 |
1.364000E-02 |
| Stage1-vs-Stage4 |
2.743500E-02 |
| Stage2-vs-Stage3 |
3.702600E-01 |
| Stage2-vs-Stage4 |
1.878600E-01 |
| Stage3-vs-Stage4 |
5.837600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6295853555448E-12 |
| Normal-vs-AfricanAmerican |
5.23959997611456E-09 |
| Normal-vs-Asian |
1.66453999999039E-05 |
| Caucasian-vs-AfricanAmerican |
1.174020E-01 |
| Caucasian-vs-Asian |
3.910400E-01 |
| AfricanAmerican-vs-Asian |
2.509600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91269222682422E-12 |
| Normal-vs-Female |
3.53450602119665E-12 |
| Male-vs-Female |
9.602400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.81760162476508E-11 |
| Normal-vs-Extreme_Weight |
1.51709755868978E-11 |
| Normal-vs-Obese |
3.38939987187814E-11 |
| Normal-vs-Extreme_Obese |
7.483900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.576200E-01 |
| Normal_Weight-vs-Obese |
6.070200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.515600E-01 |
| Extreme_Weight-vs-Obese |
5.323200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.663600E-01 |
| Obese-vs-Extreme_Obese |
5.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68510000397859E-08 |
| Normal-vs-Age(41-60Yrs) |
2.16215934045749E-12 |
| Normal-vs-Age(61-80Yrs) |
8.89510687329675E-13 |
| Normal-vs-Age(81-100Yrs) |
2.61050000505136E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.131400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.074200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.339800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.932000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.842200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.6520010066331E-11 |
| Normal-VS-Type2 PRCC |
2.22044604925031E-16 |
| Normal-VS-KIRP CIMP |
4.83689976960022E-10 |
| Normal-VS-Unclassified PRCC |
1.05879749412452E-11 |
| Type1 PRCC-VS-Type2 PRCC |
2.60610000024641E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.219600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.508300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.547400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.641770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.614630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.99360577730113E-15 |
| Normal-vs-N1 |
8.26005930321116E-14 |
| Normal-vs-N2 |
1.00170000072453E-08 |
| N0-vs-N1 |
3.578400E-01 |
| N0-vs-N2 |
4.935700E-02 |
| N1-vs-N2 |
8.958000E-02 |
|
|
